JP Stock MarketDetailed Quotes

4503 Astellas Pharma

Watchlist
  • 1556.5
  • 0.00.00%
20min DelayMarket to Open Dec 13 15:30 JST
2.82TMarket Cap164.36P/E (Static)

Astellas Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
26.17%473.12B
5.60%1.6T
17.04%414.6B
4.91%421.93B
3.09%392.15B
-1.78%374.99B
17.16%1.52T
16.58%354.25B
18.07%402.18B
16.86%380.39B
Cost of revenue
32.18%91.14B
1.43%292.49B
17.58%73.23B
1.98%75.9B
18.52%74.41B
-22.42%68.95B
13.97%288.35B
5.71%62.28B
7.30%74.42B
0.44%62.78B
Gross profit
24.82%381.99B
6.58%1.31T
16.92%341.37B
5.58%346.04B
0.04%317.74B
4.48%306.04B
17.94%1.23T
19.19%291.97B
20.82%327.76B
20.76%317.61B
Operating expense
28.04%334.17B
17.61%1.29T
13.86%387.27B
23.00%327.17B
38.16%320.95B
0.27%260.99B
20.45%1.1T
32.24%340.12B
22.06%266B
11.17%232.3B
Selling and administrative expenses
23.01%206.88B
17.43%740.11B
21.25%193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
11.85%159.3B
19.94%163.02B
15.86%154.56B
-General and administrative expense
23.01%206.88B
17.43%740.11B
21.25%193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
11.85%159.3B
19.94%163.02B
15.86%154.56B
Research and development costs
34.41%86.82B
6.54%294.19B
11.10%77.85B
11.23%74.39B
18.70%77.36B
-12.72%64.59B
12.24%276.13B
2.51%70.08B
14.14%66.88B
7.28%65.17B
Depreciation and amortization
285.88%34.99B
157.10%98.82B
252.48%32.65B
252.34%32.44B
167.43%24.67B
-15.61%9.07B
35.90%38.44B
15.26%9.26B
17.02%9.21B
43.75%9.22B
-Depreciation
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Amortization
285.88%34.99B
157.10%98.82B
252.48%32.65B
252.34%32.44B
167.43%24.67B
-15.61%9.07B
35.90%38.44B
15.26%9.26B
17.02%9.21B
43.75%9.22B
Other operating expenses
-54.99%10.38B
6.54%167.81B
-18.29%83.84B
-16.34%23.41B
1,106.04%42.94B
-40.00%23.06B
51.00%157.52B
107.59%102.61B
50.26%27.98B
-67.16%3.56B
Total other operating income
25.16%4.9B
138.63%8.69B
-80.44%220M
136.65%2.57B
1,454.98%3.28B
-75.97%3.92B
-76.13%3.64B
-89.82%1.13B
-64.64%1.09B
-91.37%211M
Operating profit
6.13%47.82B
-85.60%18.95B
4.67%-45.9B
-69.45%18.87B
-103.77%-3.22B
38.09%45.06B
0.45%131.56B
-293.17%-48.14B
15.77%61.76B
57.80%85.31B
Net non-operating interest income (expenses)
-115.34%-162M
17.79%-550M
-116.67%-62M
-1.23%-1.65B
-94.90%105M
171.89%1.06B
-155.75%-669M
-88.26%372M
-84.18%-1.63B
349.94%2.06B
Non-operating interest income
14.75%4.33B
41.25%11.46B
68.74%4.12B
0.60%1.18B
-33.41%2.37B
307.34%3.78B
31.89%8.11B
-36.40%2.44B
181.29%1.17B
725.23%3.57B
Non-operating interest expense
65.26%4.5B
36.75%12.01B
102.03%4.19B
0.96%2.83B
50.46%2.27B
13.52%2.72B
77.39%8.78B
206.96%2.07B
115.28%2.8B
20.16%1.51B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
181.20%1.93B
-351.19%-3.17B
-2,336.04%-2.7B
45.21%-223M
-164.59%-923M
96.00%686M
157.67%1.26B
92.81%-111M
-123.61%-407M
8,831.25%1.43B
Special income (charges)
1,583.33%909M
4,491.98%9.74B
0
783.33%318M
468,100.00%9.36B
-68.24%54M
-99.13%212M
-96.15%4M
-99.85%36M
2M
Less:Other special charges
-1,583.33%-909M
-4,491.98%-9.74B
--0
-783.33%-318M
-468,100.00%-9.36B
68.24%-54M
99.13%-212M
96.15%-4M
99.85%-36M
---2M
Other non-operating income (expenses)
Income before tax
7.78%50.5B
-81.14%24.97B
-1.64%-48.66B
-71.03%17.31B
-94.00%5.33B
47.89%46.85B
-15.63%132.36B
-355.28%-47.88B
-23.70%59.76B
66.75%88.8B
Income tax
-6.04%12.89B
-76.45%7.92B
-778.08%-15.38B
-75.34%2.8B
-60.49%6.79B
99.81%13.72B
2.58%33.65B
16.89%-1.75B
-34.87%11.35B
39.29%17.18B
Net income
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
75.02%71.62B
Net income continuous operations
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.58%-46.13B
-20.50%48.41B
75.02%71.62B
Noncontrolling interests
Net income attributable to the company
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
75.02%71.62B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
75.02%71.62B
Gross dividend payment
Basic earnings per share
13.76%21
-82.47%9.51
26.36%-18.55
-69.54%8.09
-102.06%-0.81
35.84%18.46
-19.14%54.24
-468.62%-25.19
-19.17%26.56
77.91%39.3
Diluted earnings per share
13.68%20.94
-82.49%9.47
26.71%-18.55
-69.64%8.06
-102.06%-0.81
35.54%18.42
-19.33%54.09
-471.33%-25.31
-19.15%26.55
77.90%39.28
Dividend per share
0
16.67%70
16.67%35
0
16.67%35
0
20.00%60
20.00%30
0
20.00%30
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue 26.17%473.12B5.60%1.6T17.04%414.6B4.91%421.93B3.09%392.15B-1.78%374.99B17.16%1.52T16.58%354.25B18.07%402.18B16.86%380.39B
Cost of revenue 32.18%91.14B1.43%292.49B17.58%73.23B1.98%75.9B18.52%74.41B-22.42%68.95B13.97%288.35B5.71%62.28B7.30%74.42B0.44%62.78B
Gross profit 24.82%381.99B6.58%1.31T16.92%341.37B5.58%346.04B0.04%317.74B4.48%306.04B17.94%1.23T19.19%291.97B20.82%327.76B20.76%317.61B
Operating expense 28.04%334.17B17.61%1.29T13.86%387.27B23.00%327.17B38.16%320.95B0.27%260.99B20.45%1.1T32.24%340.12B22.06%266B11.17%232.3B
Selling and administrative expenses 23.01%206.88B17.43%740.11B21.25%193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B11.85%159.3B19.94%163.02B15.86%154.56B
-General and administrative expense 23.01%206.88B17.43%740.11B21.25%193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B11.85%159.3B19.94%163.02B15.86%154.56B
Research and development costs 34.41%86.82B6.54%294.19B11.10%77.85B11.23%74.39B18.70%77.36B-12.72%64.59B12.24%276.13B2.51%70.08B14.14%66.88B7.28%65.17B
Depreciation and amortization 285.88%34.99B157.10%98.82B252.48%32.65B252.34%32.44B167.43%24.67B-15.61%9.07B35.90%38.44B15.26%9.26B17.02%9.21B43.75%9.22B
-Depreciation --0--0--0--0--0--0--0--0--0--0
-Amortization 285.88%34.99B157.10%98.82B252.48%32.65B252.34%32.44B167.43%24.67B-15.61%9.07B35.90%38.44B15.26%9.26B17.02%9.21B43.75%9.22B
Other operating expenses -54.99%10.38B6.54%167.81B-18.29%83.84B-16.34%23.41B1,106.04%42.94B-40.00%23.06B51.00%157.52B107.59%102.61B50.26%27.98B-67.16%3.56B
Total other operating income 25.16%4.9B138.63%8.69B-80.44%220M136.65%2.57B1,454.98%3.28B-75.97%3.92B-76.13%3.64B-89.82%1.13B-64.64%1.09B-91.37%211M
Operating profit 6.13%47.82B-85.60%18.95B4.67%-45.9B-69.45%18.87B-103.77%-3.22B38.09%45.06B0.45%131.56B-293.17%-48.14B15.77%61.76B57.80%85.31B
Net non-operating interest income (expenses) -115.34%-162M17.79%-550M-116.67%-62M-1.23%-1.65B-94.90%105M171.89%1.06B-155.75%-669M-88.26%372M-84.18%-1.63B349.94%2.06B
Non-operating interest income 14.75%4.33B41.25%11.46B68.74%4.12B0.60%1.18B-33.41%2.37B307.34%3.78B31.89%8.11B-36.40%2.44B181.29%1.17B725.23%3.57B
Non-operating interest expense 65.26%4.5B36.75%12.01B102.03%4.19B0.96%2.83B50.46%2.27B13.52%2.72B77.39%8.78B206.96%2.07B115.28%2.8B20.16%1.51B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 181.20%1.93B-351.19%-3.17B-2,336.04%-2.7B45.21%-223M-164.59%-923M96.00%686M157.67%1.26B92.81%-111M-123.61%-407M8,831.25%1.43B
Special income (charges) 1,583.33%909M4,491.98%9.74B0783.33%318M468,100.00%9.36B-68.24%54M-99.13%212M-96.15%4M-99.85%36M2M
Less:Other special charges -1,583.33%-909M-4,491.98%-9.74B--0-783.33%-318M-468,100.00%-9.36B68.24%-54M99.13%-212M96.15%-4M99.85%-36M---2M
Other non-operating income (expenses)
Income before tax 7.78%50.5B-81.14%24.97B-1.64%-48.66B-71.03%17.31B-94.00%5.33B47.89%46.85B-15.63%132.36B-355.28%-47.88B-23.70%59.76B66.75%88.8B
Income tax -6.04%12.89B-76.45%7.92B-778.08%-15.38B-75.34%2.8B-60.49%6.79B99.81%13.72B2.58%33.65B16.89%-1.75B-34.87%11.35B39.29%17.18B
Net income 13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B75.02%71.62B
Net income continuous operations 13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.58%-46.13B-20.50%48.41B75.02%71.62B
Noncontrolling interests
Net income attributable to the company 13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B75.02%71.62B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B75.02%71.62B
Gross dividend payment
Basic earnings per share 13.76%21-82.47%9.5126.36%-18.55-69.54%8.09-102.06%-0.8135.84%18.46-19.14%54.24-468.62%-25.19-19.17%26.5677.91%39.3
Diluted earnings per share 13.68%20.94-82.49%9.4726.71%-18.55-69.64%8.06-102.06%-0.8135.54%18.42-19.33%54.09-471.33%-25.31-19.15%26.5577.90%39.28
Dividend per share 016.67%7016.67%35016.67%35020.00%6020.00%30020.00%30
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Heat List
JP
Overall
Symbol
Price
% Chg

No Data